Structure Therapeutics Inc. (GPCR) Ownership

$26.66

south_east
-$0.43 (-1.59%)
Day's range
$26.19
Day's range
$27.68

Structure Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 7.79 M $211.15 M   0.20% 4.93%
FMR LLC 02/13/2025 6.08 M $164.86 M   -0.81% 3.85%
JANUS HENDERSON GROUP PLC 02/14/2025 4.16 M $112.82 M   5.13% 2.63%
CAPITAL RESEARCH GLOBAL INVESTORS 02/13/2025 3.54 M $95.93 M   0.20% 2.24%
DEEP TRACK CAPITAL, LP 02/14/2025 2.80 M $75.94 M   129.41% 1.77%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 2.06 M $55.80 M   -18.56% 1.30%
FEDERATED HERMES, INC. 02/13/2025 2.05 M $55.49 M   -15.16% 1.30%
BVF INC/IL 02/14/2025 1.77 M $48.04 M   -20.88% 1.12%
VESTAL POINT CAPITAL, LP 02/14/2025 1.73 M $46.78 M   50.00% 1.09%
CAPITAL INTERNATIONAL INVESTORS 02/13/2025 1.62 M $43.91 M   6.80% 1.03%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 1.52 M $41.15 M   -20.00% 0.96%
CITADEL ADVISORS LLC 02/14/2025 1.48 M $40.12 M   1.92% 0.94%
AMERIPRISE FINANCIAL INC 02/14/2025 1.42 M $38.51 M   29.40% 0.90%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 1.39 M $37.81 M   -33.12% 0.88%
FIL LTD 02/13/2025 1.30 M $35.26 M   -0.80% 0.82%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 1.08 M $29.32 M   1.60% 0.68%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 1.06 M $28.83 M   0.00% 0.67%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 791.13 K $21.46 M   45.07% 0.50%
MILLENNIUM MANAGEMENT LLC 02/14/2025 751.01 K $20.37 M   -17.60% 0.48%
FRANKLIN RESOURCES INC 02/12/2025 738.09 K $20.02 M   4.53% 0.47%
CASDIN CAPITAL, LLC 02/14/2025 700.00 K $18.98 M   0.00% 0.44%
LOGOS GLOBAL MANAGEMENT LP 02/14/2025 700.00 K $18.98 M   -44.00% 0.44%
ORBIMED ADVISORS LLC 02/14/2025 652.03 K $17.68 M   69.93% 0.41%
AMERICAN CENTURY COMPANIES INC 02/11/2025 612.62 K $16.61 M   12.35% 0.39%
BLACKROCK, INC. 02/07/2025 610.59 K $16.56 M   -10.22% 0.39%
MARSHALL WACE, LLP 02/13/2025 583.21 K $15.82 M   339.57% 0.37%
GOLDMAN SACHS GROUP INC 02/11/2025 582.87 K $15.81 M   -18.23% 0.37%
02/14/2025 569.40 K $15.44 M   100.00% 0.36%
02/14/2025 500.00 K $13.56 M   100.00% 0.32%
BELLEVUE GROUP AG 02/14/2025 485.05 K $13.15 M   -22.98% 0.31%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 476.70 K $12.93 M   -61.50% 0.30%
FORESITE CAPITAL MANAGEMENT VI LLC 02/14/2025 420.00 K $11.39 M   100.00% 0.27%
FIRST LIGHT ASSET MANAGEMENT, LLC 02/14/2025 398.86 K $10.82 M   -21.21% 0.25%
MORGAN STANLEY 02/14/2025 387.18 K $10.50 M   138.28% 0.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/14/2025 373.41 K $10.13 M   -55.78% 0.24%
BAKER BROS. ADVISORS LP 02/14/2025 361.57 K $9.81 M   322.88% 0.23%
WOODLINE PARTNERS LP 02/14/2025 333.90 K $9.06 M   0.70% 0.21%
ENSIGN PEAK ADVISORS, INC 02/14/2025 308.24 K $8.36 M   67.72% 0.20%
CAMBER CAPITAL MANAGEMENT LP 02/14/2025 300.00 K $8.14 M   100.00% 0.19%
IKARIAN CAPITAL, LLC 02/14/2025 284.09 K $7.70 M   146.60% 0.18%
SC CHINA HOLDING LTD 02/14/2025 266.06 K $7.54 M   0.00% 0.17%
MILLENNIUM MANAGEMENT LLC 02/14/2025 234.00 K $6.35 M   11.96% 0.15%
ARROWMARK COLORADO HOLDINGS LLC 02/14/2025 232.91 K $6.32 M   -3.39% 0.15%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 221.00 K $5.99 M   29.24% 0.14%
SUPERSTRING CAPITAL MANAGEMENT LP 02/14/2025 216.81 K $5.88 M   -4.51% 0.14%
CANDRIAM S.C.A. 02/07/2025 215.42 K $5.84 M   59.57% 0.14%
READYSTATE ASSET MANAGEMENT LP 02/14/2025 209.34 K $5.68 M   149.22% 0.13%
ABRDN PLC 01/24/2025 171.39 K $4.65 M   -21.05% 0.11%
HANDELSBANKEN FONDER AB 02/03/2025 165.00 K $4.48 M   100.00% 0.10%
SILVERARC CAPITAL MANAGEMENT, LLC 02/14/2025 152.40 K $4.13 M   116.11% 0.10%

Structure Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 144 institutional investors and hedge funds held shares of Structure Therapeutics Inc.. The most heavily invested institutionals were:

GRIFFIN ASSET MANAGEMENT, INC.: 0

Janney Capital Management LLC: 0

M&T BANK CORP: 0

ENVESTNET ASSET MANAGEMENT INC: 0

Spire Wealth Management: 0

MONEY CONCEPTS CAPITAL CORP: 0

38.37% of Structure Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 57.88 M shares in the last 24 months. This purchase volume represents approximately $1.54 B in transactions.